Myeloma Patients Europe AISBL

Myeloma Patients Europe AISBL is an organisation in Bruxelles, Belgium that has taken part in 6 EU-funded projects since 2016, receiving €623k in EU funding.

EU funding received€623k
EU projects6
As coordinator0
Running now3
First EU project2016
Latest project2026
CountryBelgium
EU registration (PIC)935347818
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Myeloma Patients Europe AISBL's own share of each project, not the project's full budget.

  • Horizon Europe€459k · 3 projects
  • Horizon 2020€164k · 3 projects

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • iN-KEYPartner

    iNK Cell–Driven Strategies for Enhanced Multiple Myeloma ImmunotherapY

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €132ktheir share
  • CERTAINTYPartner

    A CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNT

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €102ktheir share
  • ASCERTAINPartner

    Affordability and Sustainability improvements by using new pricing, Cost-Effectiveness and ReimbursemenT models to Appraise iNnovative health technologies

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €225ktheir share
  • SISAQOL-IMIPartner

    Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  • CARAMBAPartner

    SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €116ktheir share
  • MMpredictPartner

    Validation of a personalised medicine tool for Multiple Myeloma that predicts treatment effectiveness in patients

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €49ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • cells technologies
  • ecosystems
  • entrepreneurship
  • gene therapy
  • hematology
  • immunology
  • immunotherapy
  • leukemia
  • oncology
  • personalized medicine
  • pharmaceutical drugs
  • software development
  • transcriptomes

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime